Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 3/20 | 0.61 |
| ▸ | RAB9A | P51151 | 3/20 | 0.61 |
| ▸ | LMNA | P02545 | 1/20 | 0.61 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 4/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.39 |
| ▸ | POLB | P06746 | 4/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.37 |
| ▸ | HPGD | P15428 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | KCNMA1 | Q12791 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 2/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Acetic Acid SCHEMBL6571740 | 0.91 | NPC1 (0.56) | NPC1RAB9ALMNATRPA1MEN1 | |
| SCHEMBL9868391 | 0.89 | NPC1 (0.47) | NPC1RAB9ALMNATRPA1MEN1 | |
| SCHEMBL7921927 | 0.84 | NPC1 (0.46) | NPC1RAB9ALMNATRPA1MEN1 | |
| SCHEMBL14126172 | 0.83 | NPC1 (0.66) | NPC1RAB9ALMNAMEN1KMT2A | |
| SCHEMBL10728649 | 0.83 | RAB9A (0.61) | NPC1RAB9ALMNAMEN1KMT2A | |
| SCHEMBL14017581 | 0.83 | NPC1 (0.43) | NPC1RAB9ALMNATRPA1MEN1 | |
| SCHEMBL10547324 | 0.82 | NPC1 (0.64) | NPC1RAB9ALMNATRPA1MEN1 | |
| SCHEMBL28696120 | 0.81 | NPC1 (0.62) | NPC1RAB9ALMNAMEN1KMT2A | |
| SCHEMBL7170091 | 0.80 | NPC1 (0.54) | NPC1RAB9ALMNAMEN1KMT2A | |
| SCHEMBL29046137 | 0.79 | NPC1 (0.65) | NPC1RAB9ALMNAMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 839 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12595368-B2 | UV/HEVL-filtering contact lenses | ALCON INC. (CH) | 2026-04-07 | — | — | US | claimed |
| EP-4713720-A2 | HIGH-ENERGY-VIOLET-ABSORBING VINYLIC MONOMERS | Alcon Inc. (CH) | 2026-03-25 | — | — | EP | claimed |
| EP-4713721-A1 | UV/HEVL-FILTERING SILICONE HYDROGEL CONTACT LENSES | Alcon Inc. (CH) | 2026-03-25 | — | — | EP | claimed |
| US-20250223392-A1 | HYDROPHILIZED POLYDIORGANOSILOXANE VINYLIC CROSSLINKERS AND USES THEREOF | ALCON INC (CH) | 2025-07-10 | — | — | US | claimed |
| US-12286501-B2 | Hydrophilized polydiorganosiloxane vinylic crosslinkers and uses thereof | ALCON INC. (CH) | 2025-04-29 | — | — | US | claimed |
| EP-4529621-A1 | UV/HEVL-FILTERING CONTACT LENSES | Alcon Inc. (CH) | 2025-04-02 | — | — | EP | claimed |
| WO-2025032504-A2 | UV/HEVL-FILTERING SILICONE HYDROGEL CONTACT LENSES | ALCON INC. (CH) | 2025-02-13 | — | — | WO | claimed |
| US-20250052927-A1 | UV/HEVL-FILTERING SILICONE HYDROGEL CONTACT LENSES | ALCON INC (CH) | 2025-02-13 | — | — | US | claimed |
| CN-119137510-A | UV/HEVL filtering contact lenses | 爱尔康公司 | 2024-12-13 | — | — | CN | claimed |
| US-20240392055-A1 | UV/HEVL-FILTERING SILICONE HYDROGEL CONTACT LENSES | ALCON INC (CH) | 2024-11-28 | — | — | US | claimed |
| WO-2010133680-A1 | ACTINICALLY-CROSSLINKABLE SILOXANE-CONTAINING COPOLYMERS | NOVARTIS AG (CH) | 2010-11-25 | — | — | WO | claimed |
| US-5980851-A | Transparent electrically conductive plate | NIPPON OIL, CO., LTD. (JP) | 1999-11-09 | — | — | US | claimed |
| US-5770314-A | Transparent electrically conductive plate | NIPPON OIL CO., LTD. (JP) | 1998-06-23 | — | — | US | claimed |
| US-5382633-A | Modified polymers | 3I RESEARCH EXPLOITATION LIMITED (GB) | 1995-01-17 | — | — | US | claimed |
| US-5002979-A | Hyydrogenorganosilicon monomer, organosilicon, fluoroorgano monomer, a hydrophobic monomer and a crosslinking agent | BAUSCH & LOMB INCORPORATED (US) | 1991-03-26 | — | — | US | claimed |
| EP-0211067-B1 | OXYGEN-PERMEABLE LENSES | Bausch & Lomb Incorporated (US) | 1991-03-13 | — | — | EP | claimed |
| EP-0211067-A1 | OXYGEN-PERMEABLE LENSES. | BAUSCH & LOMB (US) | 1987-02-25 | — | — | EP | claimed |
| EP-0209597-A1 | EXTENDED-WEAR LENSES | Bausch & Lomb Incorporated (US) | 1987-01-28 | — | — | EP | claimed |
| WO-1986004342-A1 | OXYGEN-PERMEABLE LENSES | BAUSCH AND LOMB INCORPORATED (US) | 1986-07-31 | — | — | WO | claimed |
| WO-1986004343-A1 | EXTENDED-WEAR LENSES | BAUSCH AND LOMB INCORPORATED (US) | 1986-07-31 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12595368-B2 | UV/HEVL-filtering contact lenses | UACA, HSPA4L, RAD54L | NPC1 3998/4885RAB9A 4835/4885LMNA 2948/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.